Terms: = Gastric cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Diagnosis
4 results:
1. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
[TBL] [Abstract] [Full Text] [Related]
2. Detection of tert Promoter Mutations Using Targeted Next-Generation Sequencing: Overcoming GC Bias through Trial and Error.
Lee H; Lee B; Kim DG; Cho YA; Kim JS; Suh YL
Cancer Res Treat; 2022 Jan; 54(1):75-83. PubMed ID: 33940787
[TBL] [Abstract] [Full Text] [Related]
3. [Measurement of telomerase activity and telomerase reverse transcriptase expression in gastric fluid and tissue for early diagnosis of stomach cancer].
Lee HJ; Myung SJ; Park YH; Cho YK; Jung HY; Lee GH; Hong WS; Yang SK; Kim JH; Min YI
Korean J Gastroenterol; 2003 Sep; 42(3):183-9. PubMed ID: 14532739
[TBL] [Abstract] [Full Text] [Related]
4. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas.
Yasui W; Tahara H; Tahara E; Fujimoto J; Nakayama J; Ishikawa F; Ide T; Tahara E
Jpn J Cancer Res; 1998 Nov; 89(11):1099-103. PubMed ID: 9914776
[TBL] [Abstract] [Full Text] [Related]
